SARS-CoV-2 lambda variant escapes immune response via spike mutations
By Dr. Liji Thomas, MD | Aug 20 2021
Reviewed by Benedette Cuffari, M.Sc.The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for the coronavirus disease 2019 (COVID-19), has caused almost 4.5 million deaths worldwide and infected almost 211 million as of August 19, 2021.
To date, millions of doses of the COVID-19 vaccines have been deployed globally, which has significantly reduced the rate of infections, hospitalizations, and deaths from COVID-19. Despite these efforts, emerging SARS-CoV-2 variants that evade neutralization by antibodies to earlier lineages have threatened the efficacy of current vaccines.
A new study published on the preprint server bioRxiv* explores the mechanism by which the SARS-CoV-2 lambda variant has acquired immune evasion capabilities above that of the wildtype. This appears to involve shortening of the epitopes on the viral spike protein, as well as acquiring additional sites that can be N-glycosylated. . .
https://www.news-medical.net/news/20210820/SARS-CoV-2-lambda-variant-escapes-immune-response-via-spike-mutations.aspx
Gee, if only someone could have warned us about this eight months ago. Oh, wait . . .
Maybe they should have developed a vaccine that actually works against the virus itself instead of that cute coat it wears instead of engaging in some worldwide mRNA experiment.